Experimental research of host macrophage canceration induced by glioma stem progenitor cells

Wang,Aidong; Dai,Xingliang; Cui,Baoqian; Fei,Xifeng; Chen,Yanming; Zhang,Jinshi; Zhang,Quanbin; Zhao,Yaodong; Wang,Zhimin; Chen,Hua; Lan,Qing; Dong,Jun; Huang,Qiang

doi:10.3892/mmr.2014.3032

Experimental research of host macrophage canceration induced by glioma stem progenitor cells

Authors:
- Aidong Wang
- Xingliang Dai
- Baoqian Cui
- Xifeng Fei
- Yanming Chen
- Jinshi Zhang
- Quanbin Zhang
- Yaodong Zhao
- Zhimin Wang
- Hua Chen
- Qing Lan
- Jun Dong
- Qiang Huang
View Affiliations

Affiliations: Department of Neurosurgery, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215004, P.R. China, Department of Neurosurgery, Suzhou Kowloon Hospital, School of Medicine, Shanghai Jiaotong University, Suzhou, Jiangsu 215021, P.R. China, Department of Neurosurgery, Shanghai 10th People's Hospital, Shanghai Tongji University, Shanghai, Jiangsu 200072, P.R. China , Department of Neurosurgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu 210006, P.R. China
Published online on: December 2, 2014 https://doi.org/10.3892/mmr.2014.3032
Pages: 2435-2442
Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The involvement of tumor‑associated macrophages in tumor progression is an indisputable fact. However, whether the growth‑promotion effects of macrophages towards tumors in the aggressive stage affect their own canceration remains unknown. In the present study, human glioma stem/progenitor cells transfected with red fluorescent protein gene (SU3‑RFP) were seeded inside the abdominal cavity of transgenic nude mice, of which all nucleated cells could express green fluorescent protein (GFP), forming a tumor model with a double‑color RFP/GFP fluorescent tracer. Ascites and tumor nodules from tumor‑bearing mice were cultured, then the GFP+ cells were separated for clonal culture and further related phenotypic characterization and tumorigenicity tests. It was observed that the GFP+ cells isolated from ascites and solid tumors exhibited unlimited proliferative potential; the monoclonal cells were mouse‑original, had a cancer cell phenotype and expressed the macrophage marker protein CD68. Thus, in the abdominal tumor model with double‑color fluorescent tracer, macrophages recruited by tumor cells not only promoted tumor cell growth, but also exhibited their own canceration. This discovery is significant for the further study of tumor tissue remodeling and the tumor microenvironment.

View Figures

View References

1	Coussens LM and Werb Z: Inflammation and cancer. Nature. 420:860–867. 2002. View Article : Google Scholar : PubMed/NCBI
2	Fukuda K, Kobayashi A and Watabe K: The role of tumor-associated macrophage in tumor progression. Front Biosci (Schol Ed). 4:787–798. 2012. View Article : Google Scholar
3	Galdiero MR, Garlanda C, Jaillon S, Marone G and Mantovani A: Tumor associated macrophages and neutrophils in tumor progression. J Cell Physiol. 228:1404–1412. 2013. View Article : Google Scholar
4	Lin EY, Li JF, Gnatovskiy L, et al: Macrophages regulate the angiogenic switch in a mouse model of breast cancer. Cancer Res. 66:11238–11246. 2006. View Article : Google Scholar : PubMed/NCBI
5	Kurahara H, Takao S, Maemura K, et al: M2-polarized tumor-associated macrophage infiltration of regional lymph nodes is associated with nodal lymphangiogenesis and occult nodal involvement in pN0 pancreatic cancer. Pancreas. 42:155–159. 2013. View Article : Google Scholar
6	Behnes CL, Bremmer F, Hemmerlein B, et al: Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma. Virchows Arch. 464:191–196. 2014. View Article : Google Scholar
7	Shirabe K, Mano Y, Muto J, et al: Role of tumor-associated macrophages in the progression of hepatocellular carcinoma. Surg Today. 42:1–7. 2012. View Article : Google Scholar
8	Obeid E, Nanda R, Fu YX and Olopade OI: The role of tumor-associated macrophages in breast cancer progression (review). Int J Oncol. 43:5–12. 2013.PubMed/NCBI
9	Lee CH, Liu SY, Chou KC, et al: Tumor-associated macrophages promote oral cancer progression through activation of the Axl signaling pathway. Ann Surg Oncol. 21:1031–1037. 2014. View Article : Google Scholar
10	Balkwill FR: The chemokine system and cancer. J Pathol. 226:148–157. 2012. View Article : Google Scholar
11	Pollard JW: Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 4:71–78. 2004. View Article : Google Scholar : PubMed/NCBI
12	Allavena P, Sica A, Solinas G, Porta C and Mantovani A: The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol. 66:1–9. 2008. View Article : Google Scholar
13	Solinas G, Germano G, Mantovani A and Allavena P: Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol. 86:1065–1073. 2009. View Article : Google Scholar : PubMed/NCBI
14	Pello OM and Andrés V: Role of c-MYC in tumor-associated macrophages and cancer progression. Oncoimmunology. 2:e229842013. View Article : Google Scholar : PubMed/NCBI
15	Charles NA, Holland EC, Gilbertson R, Glass R and Kettenmann H: The brain tumor microenvironment. Glia. 59:1169–1180. 2011. View Article : Google Scholar : PubMed/NCBI
16	Bouvet M, Tsuji K, Yang M, et al: In vivo color-coded imaging of the interaction of colon cancer cells and splenocytes in the formation of liver metastases. Cancer Res. 66:11293–11297. 2006. View Article : Google Scholar : PubMed/NCBI
17	Dong J, Dai XL, Lu ZH, et al: Incubation and application of transgenic green fluorescence nude mice in visualization studies on glioma tissue remodeling. Chin Med J (Engl). 125:4349–4354. 2012.
18	Wan Y, Fei XF, Wang ZM, et al: Expression of miRNA-125b in the new highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer. 31:207–214. 2012. View Article : Google Scholar : PubMed/NCBI
19	Lu ZH, Lv K, Zhang JS, et al: Establishment of a green fluorescent protein tracing murine model focused on the functions of host components in necrosis repair and the niche of subcutaneously implanted glioma. Oncol Rep. 31:657–664. 2014.
20	Seabright M: A rapid banding technique for human chromosomes. Lancet. 2:971–972. 1971. View Article : Google Scholar : PubMed/NCBI
21	Parodi B, Aresu O, Bini D, et al: Species identification and confirmation of human and animal cell lines: a PCR-based method. Biotechniques. 32:432–434. 436438–440. 2002.PubMed/NCBI
22	Raschke WC, Baird S, Ralph P and Nakoinz I: Functional macrophage cell lines transformed by Asbelson leukemia virus. Cell. 15:261–267. 1978. View Article : Google Scholar : PubMed/NCBI
23	Kerkar SP and Restifo NP: Cellular constituents of immune escape within the tumor microenvironment. Cancer Res. 72:3125–3130. 2012. View Article : Google Scholar : PubMed/NCBI
24	Shabo I and Svanvik J: Expression of macrophage antigens by tumor cells. Adv Exp Med Biol. 714:141–150. 2011. View Article : Google Scholar : PubMed/NCBI
25	Mossor DM: The many faces of macrophage activation. J Leukoc Biol. 73:209–212. 2003. View Article : Google Scholar
26	Mora R and Regnier-Vigouroux A: Autophagy-driven cell fate decision maker: activated microglia induce specific death of glioma cells by a blockade of basal autophagic flux and secondary apoptosis/necrosis. Autophagy. 5:419–421. 2009. View Article : Google Scholar : PubMed/NCBI
27	Wu A, Wei J, Kong LY, et al: Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol. 12:1113–1125. 2010. View Article : Google Scholar : PubMed/NCBI
28	Waldron JS, Yang I, Han S, et al: Implications for immunotherapy of tumor-mediated T-cell apoptosis associated with loss of the tumor suppressor PTEN in glioblastoma. J Clin Neurosci. 17:1543–1547. 2010. View Article : Google Scholar : PubMed/NCBI
29	Goldenberg DM and Pavia RA: Malignant potential of murine stromal cells after transplantation of human tumors into nude mice. Science. 212:65–67. 1981. View Article : Google Scholar : PubMed/NCBI
30	Sparrow S, Jones M, Billington S and Stace B: The in vivo malignant transformation of mouse fibroblasts in the presence of human tumour xenografts. Br J Cancer. 53:793–797. 1986. View Article : Google Scholar : PubMed/NCBI
31	Gupta V, Rajaraman S, Gadson P and Costanzi JJ: Primary transfection as a mechanism for transformation of host cells by human tumor cells implanted in nude mice. Cancer Res. 47:5194–5201. 1987.PubMed/NCBI
32	Russell PJ, Brown J, Grimmond S, et al: Tumour-induced host stromal-cell transformation: induction of mouse spindle-cell fibrosarcoma not mediated by gene transfer. Int J Cancer. 46:299–309. 1990. View Article : Google Scholar : PubMed/NCBI
33	Gupta V, Rajaraman S and Eberle R: Spontaneous induction of malignancy in mouse cells by a human small cell lung cancer implanted in nude mice. Carcinogenesis. 11:713–722. 1990. View Article : Google Scholar : PubMed/NCBI
34	Bryzgalov IP, Iudicheva TV, Galetskiĭ SA, Solov’ev IuN and Revazova ES: Induction of stromal cell transformation in xenografts of human colonic cancer. Biull Eksp Biol Med. 113:399–402. 1992.(In Russian). View Article : Google Scholar : PubMed/NCBI
35	Cate CC, Belloni DR and Marin-Padilla M: Acquisition and enhanced expression of the metastatic phenotype following transfections of genomic mouse tumor DNA containing human SCLC gene sequences. Clin Exp Metastasis. 13:203–217. 1995. View Article : Google Scholar : PubMed/NCBI
36	Ozen M, Multani AS, Kuniyasu H, et al: Specific histologic and cytogenetic evidence for in vivo malignant transformation of murine host cells by three human prostate cancer cell lines. Oncol Res. 9:433–438. 1997.PubMed/NCBI
37	Pathak S, Nemeth MA, Multani AS, et al: Can cancer cells transform normal host cells into malignant cells? Br J Cancer. 76:1134–1138. 1997. View Article : Google Scholar : PubMed/NCBI
38	Sinkovics JG: Horizontal gene transfers and cell fusions in microbiology, immunology and oncology (Review). Int J Oncol. 35:441–465. 2009. View Article : Google Scholar : PubMed/NCBI
39	Goldenberg DM, Gold DV, Loo M, et al: Horizontal transmission of malignancy: in-vivo fusion of human lymphomas with hamster stroma produces tumors retaining human genes and lymphoid pathology. PLoS One. 8:e553242013. View Article : Google Scholar : PubMed/NCBI
40	Goldenberg DM, Zagzag D, Heselmeyer-Haddad KM, et al: Horizontal transmission and retention of malignancy, as well as functional human genes, after spontaneous fusion of human glioblastoma and hamster host cells in vivo. Int J Cancer. 131:49–58. 2012. View Article : Google Scholar :
41	Goldenberg DM: Horizontal transmission of malignancy by cell-cell fusion. Expert Opin Biol Ther. 12:S133–S139. 2012. View Article : Google Scholar : PubMed/NCBI
42	Rappa G, Mercapide J and Lorico A: Spontaneous formation of tumorigenic hybrids between breast cancer and multipotent stromal cells is a source of tumor heterogeneity. Am J Pathol. 180:2504–2515. 2012. View Article : Google Scholar : PubMed/NCBI
43	Holmgren L, Bergsmedh A and Spetz AL: Horizontal transfer of DNA by the uptake of apoptotic bodies. Vox Sang. 83:305–306. 2002. View Article : Google Scholar
44	Yu F, Hsieh WS, Petersson F, et al: Malignant cells derived from 3T3 fibroblast feeder layer in cell culture for nasopharyngeal carcinoma. Exp Cell Res. 322:193–201. 2014. View Article : Google Scholar
45	García-Olmo DC, Domínguez C, García-Arranz M, et al: Cell-free nucleic acids circulating in the plasma of colorectal cancer patients induce the oncogenic transformation of susceptible cultured cells. Cancer Res. 70:560–567. 2010. View Article : Google Scholar : PubMed/NCBI
46	García-Olmo DC, Picazo MG and García-Olmo D: Transformation of non-tumor host cells during tumor progression: theories and evidence. Expert Opin Biol Ther. 12(Suppl 1): S199–S207. 2012. View Article : Google Scholar : PubMed/NCBI
47	Durrett R, Foo J, Leder K, Mayberry J and Michor F: Intratumor heterogeneity in evolutionary models of tumor progression. Genetics. 188:461–477. 2011. View Article : Google Scholar : PubMed/NCBI
48	Lee AJ and Swanton C: Tumour heterogeneity and drug resistance: personalising cancer medicine through functional genomics. Biochem Pharmacol. 83:1013–1020. 2012. View Article : Google Scholar
49	Xu X, Hou Y, Yin X, et al: Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell. 148:886–895. 2012. View Article : Google Scholar : PubMed/NCBI
50	Hou Y, Song L, Zhu P, et al: Single-cell exome sequencing and monoclonal evolution of JAK2-negative myeloproliferative neoplasm. Cell. 148:873–885. 2012. View Article : Google Scholar : PubMed/NCBI